ELAN Elanco Animal Health Inc

BULLISH Impact: 4/10 Insider Cluster (3 insiders)
Horizon weeks Filed May 19, 2026 Processed 17d 18h ago
Insider cluster: 2 insiders, $200K total
Latest settled — T+5d ⚠ clustered
ELAN ▲ +13.74% at T+5d
LONG call ✓ call won +13.74% · α vs SPY +12.50% · entry $20.83 → $23.69
Next anchor: T+20d in 4d
Currently $24.17 · +16.05% from $20.83 entry
Entry anchored
May 19, 03:59 PM ET
via Databento tick
T+1d
+2.26%
call +2.26% · α +2.06%
$21.30
settled 24d ago
T+5d
+13.74%
call +13.74% · α +12.50%
$23.69
settled 17d ago
T+20d
call — · α —
in 4d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Elanco CEO Jeffrey Simmons and another insider made open-market purchases totaling $200K on May 15, 2026, at ~$20.09-$20.35 per share. This is a small cluster relative to the $10.9B market cap (~0.002%), but the CEO's personal cash purchase is a modest positive signal. A director also received a non-cash grant of 4,678 shares on May 21, which is routine and not economically meaningful.

Key Financial Metrics

Direction
buying
Total Value
$200.0K
Insiders
3

Actionable Insight

The CEO's personal purchase is a modest bullish signal, but the dollar amount is trivial relative to market cap. Monitor for any upcoming earnings or material announcements that may have prompted the insider buying. The historical calibration for this ticker shows poor past performance on bullish calls, so treat this as a low-conviction signal.

Key Facts

  • CEO Jeffrey Simmons bought 5,000 shares for $100K at $20.09 on May 15.
  • Rajeev Modi bought 4,900 shares for $100K at $20.35 on May 15.
  • Director Art Garcia received a non-cash grant of 4,678 shares on May 21.
  • Total cluster value of $200K is ~0.002% of $10.9B market cap.
  • Prior insider activity (30d) included 2 buys totaling $200K, consistent with this pattern.

Financial Impact

CEO and insider open-market purchases totaling $200K, representing ~0.002% of market cap.

insider ownership

Risk Factors

  • Historical reports on ELAN have underperformed, with avg T+20 alpha of -2.57% and 0% win rate.
  • The cluster size is too small to be economically meaningful for a $10.9B company.
  • No other material cross-filings (earnings, M&A, offerings) were provided to amplify the signal.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ELAN-1779828189779
5 reports for ELAN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ELAN — sortable, filterable
Type Now
May 19, 2026
24d ago
Insider Cluster
NEUTRAL ★ 3/10
$23.61 $24.58▲ +4.11%▲ +3.64%$24.17 (+2.38%)
May 19, 2026
24d ago
Insider Cluster
BULLISH ★ 4/10
$20.83 $23.69▲ +13.74%▲ +12.50%$24.17 (+16.05%)
May 19, 2026
24d ago
Insider Cluster
BULLISH ★ 5/10
$20.83 $23.96▲ +15.03%▲ +13.23%$24.17 (+16.05%)
May 6, 2026
5w ago
8-K
BULLISH ★ 8/10
$26.14 $21.43▼ −18.01%▼ −19.14%$24.17 (−7.53%)
Apr 8, 2026
9w ago
DEFA14A
NEUTRAL ★ 3/10
$23.60 $23.21▼ −1.65%▼ −5.17%$24.17 (+2.43%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (45h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access